ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 85 filers reported holding ACCELERON PHARMA INC in Q3 2014. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $53,563,000 | +6.5% | 1,480,060 | 0.0% | 85.86% | +3.0% |
| Q2 2016 | $50,292,000 | +28.8% | 1,480,060 | 0.0% | 83.36% | +13.4% |
| Q1 2016 | $39,059,000 | -45.9% | 1,480,060 | 0.0% | 73.52% | -7.8% |
| Q4 2015 | $72,168,000 | +95.8% | 1,480,060 | 0.0% | 79.74% | +23.1% |
| Q3 2015 | $36,853,000 | -38.3% | 1,480,060 | -21.6% | 64.78% | +4.3% |
| Q2 2015 | $59,715,000 | -34.5% | 1,887,319 | -21.2% | 62.12% | -18.3% |
| Q1 2015 | $91,207,000 | -9.3% | 2,396,389 | -7.1% | 76.05% | -4.0% |
| Q4 2014 | $100,528,000 | +18.6% | 2,580,291 | -8.0% | 79.21% | +0.8% |
| Q3 2014 | $84,782,000 | -11.0% | 2,803,645 | 0.0% | 78.57% | +1.0% |
| Q2 2014 | $95,240,000 | -16.8% | 2,803,645 | -15.5% | 77.81% | +3.0% |
| Q1 2014 | $114,441,000 | -7.8% | 3,317,136 | +5.9% | 75.52% | -8.4% |
| Q4 2013 | $124,076,000 | – | 3,133,234 | – | 82.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |